Skip to main content
Premium Trial:

Request an Annual Quote

PamGene Says Innogenetics to Introduce HLA Typing on its Array Platform This Year

This article has been updated from a previous version, which incorrectly described Innogenetics as a Dutch company.

 

VANCOUVER, March 27 (GenomeWeb News) - Innogenetics, a Belgian diagnostics company, will begin offering human leukocyte antigen typing on PamGene's microarray platform later this year, according to a PamGene scientific advisory board member.

 

Bertrand Jordan, who sits on PamGene's SAB, told GenomeWeb Daily News sister publication BioArray News at the World Microarray Congress here on Friday that Innogenetics is using a system specifically designed for its use called the PamStation 12 to introduce the HLA typing.

 

The companies began collaborating on the development of the PamStation 12 in May 2004.

 

Jordansaid that Innogenetics plans to introduce additional tests for the PamStation platform, including tests for cystic fibrosis and the mannose-binding lectin 2 (MBL2) gene in 2007, and for infectious disease, neurodegeneration, oncology, and immunuological diseases in 2008.

 

Jordansaid the deal is significant for PamGene, and that Innogenetics may use as many as 130 of the PS-12 stations as it adds tests to its menu. PamGene has historically sold systems that run experiments on four arrays or 96 arrays, dubbed the PamStation 4 and PamStation 96, respectively, but Jordan said that the company, which contracts out its manufacturing, was able to design throughput levels to meet the needs of its clients.

 

Innogenetics does not have exclusive rights to the PS-12, however. "PamGene will be able to sell PS-12 outside of Innogenetics," Jordan said.

 

Jordansaid that the deal with Innogenetics is significant for PamGene's three-dimensional array technology in the diagnostic arena.

 

"Array diagnostics still have some difficulty getting into the marketplace due to a lot of competition from RT-PCR," he said.  He added that PamGene's 3D array technology is not yet "mainstream" due to "a lack of high-profile collaborations and papers."   

The Scan

Shape of Them All

According to BBC News, researchers have developed a protein structure database that includes much of the human proteome.

For Flu and More

The Wall Street Journal reports that several vaccine developers are working on mRNA-based vaccines for influenza.

To Boost Women

China's Ministry of Science and Technology aims to boost the number of female researchers through a new policy, reports the South China Morning Post.

Science Papers Describe Approach to Predict Chemotherapeutic Response, Role of Transcriptional Noise

In Science this week: neural network to predict chemotherapeutic response in cancer patients, and more.